Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in <i>bla</i><sub>CTX-M-1</sub> Encoding <i>Escherichia coli</i>

Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in <i>bla</i><sub>CTX-M-1</sub> Encoding <i>Escherichia coli</i>

Due to the rapid spread of CTX-M type ESBLs, the rate of resistance to third-generation cephalosporin has increased among Gram-negative bacteria, especially in <i>Escherichia coli</i>, and there is a need to find ways to re-sensitize ESBL <i>E. coli</i> to cephalosporin treat...

Full description

Bibliographic Details
Main Authors: Mosaed Saleh A. Alobaidallah, Vanesa García, Richard De Mets, Sandra M. Wellner, Line E. Thomsen, Ana Herrero-Fresno, John Elmerdahl Olsen
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Antibiotics
Subjects:
<i>Escherichia coli</i>
cefotaxime
gentamicin
antibiotic resistance
extended-spectrum beta-lactamase
combination treatment
Online Access:https://www.mdpi.com/2079-6382/12/6/993

Similar Items

Similar Items